Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Integrated Methods Redefine Contrasting Mechanisms Governing Foxp3 Induction and Maintenance

Control of Foxp3 Induction and Maintenance by Sequential Histone Acetylation and DNA Demethylation.

Foxp3 Enhancers Synergize to Maximize Regulatory T Cell Suppressive Capacity.

Dynamic Foxp3-chromatin Interaction Controls Tunable Treg Cell Function.

DNA demethylation switches the drivers of Foxp3 expression to maintain regulatory T cell identity

Advances In Distinguishing Natural From Induced Foxp3(+) Regulatory T Cells

Advances in Distinguishing Natural from Induced Foxp3(+) Regulatory T Cells.

Control of regulatory T‐cell differentiation and function by T‐cell receptor signalling and Foxp3 transcription factor complexes

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.

Transcriptional Regulation of Foxp3 Gene: Multiple Signal Pathways on the Road

Epigenetically Modifying the Foxp3 Locus for Generation of Stable Antigen-Specific Tregs As Cellular Therapeutics

Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation

Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

Foxp3(+) Treg Cells and Systems Biology Approaches to Studying Their Function

An integrated transcription factor framework for Treg identity and diversity

FOXP3 Activation in Treg Cells, - Atomic Level Aspects of FOXP3 Structure and Biochemistry That Govern Function (89.4)

Sustained Store-Operated Calcium Entry Utilizing Activated Chromatin State Leads to Instability in Itregs

You, Me and Foxp3: Immune Regulation for Two.

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Transcriptional regulation of Foxp3 in regulatory T cells